Overview: Allergy House Dust TestIntroduction: The Allergy House Dust Test detects IgE antibodies to house dust, particularly dust mites, which may cause sneezing, coughing, or asthma when exposed. Following 2023 AAAAI guidelines, it uses an immunoassay for high sensitivity, aiding in confirming environmental allergies. This test is critical for guiding avoidance strategies and improving outcomes in allergology.
Other Names: Allergy House Dust Assay, House Dust IgE Test.
FDA Status: Laboratory-developed test (LDT) meeting allergology standards for diagnostic accuracy.
Historical Milestone: Environmental allergy testing began in the 1970s with skin tests. Specific IgE immunoassays emerged in the 1980s, and by the 2000s, advanced assays improved specificity for dust mite allergens.
Purpose: Diagnoses house dust allergies, guides avoidance, and monitors allergic responses in patients with respiratory symptoms triggered by dust exposure.
Test Parameters: 1. House Dust IgE
Pretest Condition: No fasting required. Collect serum or saliva at any time, preferably during dust exposure or symptom onset. Report symptoms like sneezing, coughing, or asthma, and list medications like antihistamines.
Specimen: 2-5 mL serum (SST) or 1-2 mL saliva (sterile container). Centrifuge serum within 1 hour. Transport in a biohazard bag within 8 hours.
Sample Stability at Room Temperature: 8 hours
Sample Stability at Refrigeration: 7 days
Sample Stability at Frozen: 6 months
Medical History: Document allergic symptoms, dust exposure history, or family history of allergies or asthma. Include current medications, especially antihistamines or corticosteroids.
Consent: Written consent required, explaining the tests purpose, diagnostic implications, and potential need for avoidance strategies.
Procedural Considerations: Uses an immunoassay to measure house dust-specific IgE. Results are available in 1-2 days, supporting rapid diagnosis.
Factors Affecting Result Accuracy: Antihistamines may suppress IgE levels, causing false negatives. Hemolysis or improper storage can degrade samples. Low dust exposure may reduce sensitivity.
Clinical Significance: Elevated house dust-specific IgE confirms allergy, prompting avoidance (e.g., dust mite covers, air purifiers). Normal levels may require skin testing for confirmation.
Specialist Consultation: Consult an allergist for result interpretation. A pulmonology referral is advised for asthma-related cases.
Additional Supporting Tests: Skin prick test, total IgE, or dust mite panel to confirm house dust allergy or identify cross-reactive allergens.
Test Limitations: False negatives may occur with antihistamine use or low dust exposure. Cross-reactivity with other environmental allergens requires clinical correlation.
References: AAAAI Allergy Guidelines, 2023; Journal of Allergy and Clinical Immunology, Platts-Mills TA, 2022.
